HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc® (Nasdaq: ACOR) today announced that Barry Greene, Chief Operating Officer of Alnylam Pharmaceuticals (Nasdaq: ALNY), has been elected to its Board of Directors.
HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc® (Nasdaq: ACOR) today announced that Barry Greene, Chief Operating Officer of Alnylam Pharmaceuticals (Nasdaq: ALNY), has been elected to its Board of Directors.
